Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,561 | 66 | 94.0% |
| Education | $99.95 | 1 | 6.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $190.67 | 7 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $147.97 | 4 | $0 (2022) |
| Ipsen Biopharmaceuticals, Inc | $141.63 | 2 | $0 (2022) |
| PFIZER INC. | $127.45 | 12 | $0 (2022) |
| Novocure Inc. | $121.24 | 2 | $0 (2023) |
| Novo Nordisk Inc | $118.08 | 2 | $0 (2017) |
| Janssen Biotech, Inc. | $109.72 | 5 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $100.00 | 1 | $0 (2018) |
| Astellas Pharma US Inc | $76.06 | 4 | $0 (2023) |
| Celgene Corporation | $55.21 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $164.57 | 4 | Novocure Inc. ($121.24) |
| 2022 | $565.54 | 29 | Janssen Biotech, Inc. ($72.69) |
| 2021 | $34.77 | 2 | Dendreon Pharmaceuticals LLC ($18.27) |
| 2020 | $123.24 | 1 | Ipsen Biopharmaceuticals, Inc ($123.24) |
| 2019 | $56.41 | 4 | Amgen Inc. ($39.57) |
| 2018 | $484.23 | 23 | Boehringer Ingelheim Pharmaceuticals, Inc. ($100.00) |
| 2017 | $232.17 | 4 | Novo Nordisk Inc ($118.08) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/27/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $107.15 | General |
| Category: Oncology | ||||||
| 02/27/2023 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $14.09 | General |
| Category: Oncology | ||||||
| 01/25/2023 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: ONCOLOGY | ||||||
| 01/12/2023 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Oncology | ||||||
| 12/15/2022 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: BioOncology | ||||||
| 11/29/2022 | Ipsen Biopharmaceuticals, Inc | SOMATULINE DEPOT (Drug), ONIVYDE | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Oncology/Endocrinology | ||||||
| 11/22/2022 | Amgen Inc. | Nplate (Biological), XGEVA | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Hematology | ||||||
| 11/17/2022 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $15.60 | General |
| Category: Hematology | ||||||
| 10/25/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: ONCOLOGY | ||||||
| 10/12/2022 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Oncology | ||||||
| 10/04/2022 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Oncology | ||||||
| 09/30/2022 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Oncology | ||||||
| 09/27/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Oncology | ||||||
| 09/22/2022 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Oncology | ||||||
| 09/20/2022 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $28.11 | General |
| 09/15/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Rare Disease | ||||||
| 09/13/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Oncology | ||||||
| 09/12/2022 | G1 Therapeutics, Inc. | COSELA (Drug) | Food and Beverage | Cash or cash equivalent | $16.05 | General |
| Category: ONCOLOGY | ||||||
| 09/07/2022 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: ONCOLOGY | ||||||
| 08/30/2022 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: Oncology | ||||||
| 08/25/2022 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Oncology | ||||||
| 08/16/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.79 | General |
| Category: Cardiovascular | ||||||
| 08/11/2022 | GENZYME CORPORATION | CEREZYME (Biological), CERDELGA | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Genetic Disease | ||||||
| 08/02/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Oncology | ||||||
| 08/01/2022 | Incyte Corporation | JAKAFI (Drug), PEMAZYRE, MONJUVI | Food and Beverage | Cash or cash equivalent | $21.13 | General |
| Category: Hematology/Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 541 | 861 | $166,964 | $56,833 |
| 2022 | 5 | 484 | 816 | $147,018 | $64,802 |
| 2021 | 3 | 126 | 136 | $23,282 | $13,989 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 166 | 353 | $67,776 | $23,261 | 34.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 229 | 359 | $47,029 | $15,870 | 33.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 131 | 131 | $47,029 | $15,862 | 33.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 15 | 18 | $5,130 | $1,840 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 268 | 581 | $91,298 | $40,133 | 44.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 112 | 112 | $33,668 | $15,037 | 44.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 50 | 60 | $13,765 | $6,182 | 44.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 42 | 49 | $5,795 | $2,371 | 40.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 12 | 14 | $2,492 | $1,080 | 43.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 62 | 62 | $15,500 | $8,970 | 57.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 34 | 44 | $5,412 | $3,434 | 63.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 30 | 30 | $2,370 | $1,585 | 66.9% |
About Dr. Alexander Tremont, DO
Dr. Alexander Tremont, DO is a Hematology & Oncology healthcare provider based in Hendersonville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/29/2015. The National Provider Identifier (NPI) number assigned to this provider is 1922485986.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexander Tremont, DO has received a total of $1,661 in payments from pharmaceutical and medical device companies, with $164.57 received in 2023. These payments were reported across 67 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($1,561).
As a Medicare-enrolled provider, Tremont has provided services to 1,151 Medicare beneficiaries, totaling 1,813 services with total Medicare billing of $135,624. Data is available for 3 years (2021–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Student in an Organized Health Care Education/Training Program, Hematology & Oncology
- Location Hendersonville, NC
- Active Since 04/29/2015
- Last Updated 10/25/2022
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1922485986
Products in Payments
- ELIQUIS (Drug) $136.17
- ONIVYDE (Drug) $123.24
- Optune (Device) $121.24
- PRADAXA (Drug) $100.00
- XTANDI (Drug) $46.33
- LIBTAYO (Biological) $43.68
- Revlimid (Drug) $39.61
- IBRANCE (Drug) $35.03
- IMBRUVICA (Drug) $34.42
- Kyprolis (Drug) $34.08
- Nplate (Biological) $33.78
- XARELTO (Drug) $33.39
- Venclexta (Drug) $31.19
- JEVTANA (Drug) $27.51
- PROMACTA (Drug) $24.26
- CEREZYME (Biological) $23.93
- Erleada (Drug) $22.76
- Padcev (Drug) $22.20
- SUTENT (Drug) $21.56
- VENCLEXTA (Biological) $21.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Hendersonville
Don Jackson, Md, MD
Hematology & Oncology — Payments: $9,409
John Hill, Md, MD
Hematology & Oncology — Payments: $5,848
Dr. Douglas Thompson, M.d, M.D
Hematology & Oncology — Payments: $4,629
Dr. James Radford, Md, MD
Hematology & Oncology — Payments: $4,215
Laura Mcclure Barnes, M.d, M.D
Hematology & Oncology — Payments: $3,802
Dr. William Butler, Md, MD
Hematology & Oncology — Payments: $1,483